InVivo Therapeutics Holdings Corp (NVIVQ)

[Perkin78]

"The FDA has recommended that InVivo include a control arm in the study as part of a Study Design Consideration. We are in discussions with the FDA on this recommendation, and we continue to believe that our current study design is sufficient to demonstrate safety and probable benefit in support of a HDE application for marketing approval. "

Doesn't sound like a "requirement" to me. However I feel like uncertainty around this issue is what's stopping this from trading in the high teens. May get there regardless over the next couple weeks with the news today. However I would of expected more than a 10% jump out the gate.